Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 757 for “"KRAS"”.
-
Modulation of Kras Structure and Dynamics By Kras Ubiquitination and Membrane Depolarization
KRAS, a 21 kDa small GTPase protein, functions as a molecular switch playing a key role in regulating cell proliferation. Dysregulation of KRAS signaling by oncogenic mutations leads to uncontrolled cell proliferation, a hallmark of cancer cells. Attempts to therapeutically target oncogenic KRAS …
-
Oncogenic KRAS Expression and Signaling
… the level of protein expressed from the gene KRAS, but not the highly homologous gene HRAS, is limited in mammalian cells by an abundance of underrepresented (rare) codons in the encoding mRNA. KRAS mRNA from both ectopic plasmids as well as from the endogenous cellular gene is subject to …
-
Inhibition of KRas using Affimers
… cystatin scaffold has been used to inhibit KRas, which is most mutated Ras isoform. The project aims to identify Affimers that are potent inhibitors of KRas function. Three KRas binding Affimers have been identified via phage display that have shown to inhibit KRas activity by inhibiting …
-
Sensitivität und Spezifität von KRAS - Mutationsanalysen
Aufgrund der klinischen Bedeutung des KRAS Mutationsstatus sollte dieser routinemäßig vor Therapiebeginn bestimmt werden. Allerdings herrscht immer noch einige Unsicherheit darüber, welche Nachweismethode am besten für die Anwendung in der Routinedianostik geeignet ist. <br>Zu diesem Zweck wurden …
-
Quantitative Determination of Nano Delivered KRAS siRNA
… methods for the detection of therapeutic KRAS-targeting siRNA in biological systems. Physicochemical characterization showed that p5RHH-formulated siRNA nanoparticles exhibit a controlled nanoscale size distribution, moderate polydispersity, and a negative zeta potential, suggesting …
-
Metabolic Reprogramming in KRAS-driven Cancer Cells
… range of cancers. We previously reported that KRas-driven cancer cells sense exogenous lipids via de novo production of phosphatidic acid, which ultimately activates both mTOR complexes – mTORC1 and mTORC2. Activated mTORC2 phosphorylates the survival kinase Akt at Ser 473 which is required for …
-
Marketingové aktivity v oblasti mikroregionu Moravský kras
… je zaměřena na oblast mikroregionu Moravský kras, která je podrobena marketingové situační analýze destinace. Na základě získaných informací z analýzy jsou navrženy marketingové aktivity tak, aby se zvýšil zájem o tuto destinaci.
-
TARGETING KRAS SIGNALING PATHWAYS IN SK-LU-1 CELL LINE AND PRODUCING KRAS PROTEINS VIA A NOVEL ROP EXPRESSION SYSTEM
KRAS is the one of the most commonly found mutated genes in lung cancer. Currently no direct and specific treatment exists to treat lung adenocarcinomas harboring specific KRAS mutations or to target KRAS directly. This study aimed to further our knowledge in treating KRAS-mutant cancers via two …
-
An in vivo inflammatory loop potentiates KRAS blockade
KRAS inhibitors perform inferior to other targeted drugs. To investigate a possible reason for this, we treated cancer cells with KRAS inhibitors deltarasin (targeting phosphodiesterase-δ), cysmethynil (targeting isoprenylcysteine carboxylmethyltransferase), and AA12 (targeting KRASG12C), and …
-
Oncogenic Kras and Telomere Biology In Crc Progression
… Human CRCs carrying oncogenic mutations in the KRAS oncogene, henceforth referred to as KRAS*, exhibit a 25% higher propensity for developing liver metastases. Similarly, in our CRC mouse model, engineered with an inducible Kras* transgene and conditional null alleles of Apc and Tp53 (referred …
-
The Role of METTL21A in Kras-driven Cancers
… mice and crossed to PDAC models: p48Cre/+ KrasG12D/+(Kras vs. Kras; Mettl21a) and p48Cre/+; KrasG12D/+; p53fl/fl (Kras; p53 vs. Kras;p53; Mettl21a), and LUAC models:KrasG12D/+ (Kras vs. Kras; Mettl21a) and KrasG12D/+; p53fl/fl (Kras; p53 vs. Kras;p53; Mettl21a). Histopathological analysis …
-
Keimbahnmutationen im KRAS Gen verursachen das Noonan-Syndrom
… Die Mutationsanalyse der Gene HRAS, NRAS und KRAS an 174 Patienten mit PTPN11 Mutation negativem NS zeigte, dass ein kleiner Prozentsatz der Patienten Keimbahnmutationen im KRAS-Gen trägt. Diese neuen Mutationen, K-Ras V14I, T58I und D153V unterscheiden sich von den Neoplasie-assoziierten …
-
Znečištění vnášené do CHKO Moravský kras povrchovými toky
… toky na území Chráněné krajinné oblasti Moravský kras. Pro hodnocení rozsahu znečištění byly vybrány všechny povrchové toky, které přitékají do CHKO. Byl proveden průzkum zájmového území. Následně bylo pravidelně každý měsíc od dubna do listopadu 2019 prováděno měření průtoku a …
-
A CRISPR-Cas9 Repressor for Epigenetic Silencing of KRAS
KRAS is one of the most frequently mutated oncogenes in cancers. KRAS mutations have been found in in nearly 30% of all human cancers. Despite decades of study, no effective approved anti-KRAS therapies are available. The CRISPR/Cas9 (clustered regularly interspaced short palindromic …
Page 1 of 38